4.7 Review

Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?

期刊

出版社

ELSEVIER
DOI: 10.1016/j.ijbiomac.2022.02.094

关键词

TGF-beta; Prostate cancer; Immunotherapy; Biomarker; Chemotherapy; Non-coding RNA

资金

  1. US NIH [R01AI050875, R21AI121700]
  2. Santa Monica, CA
  3. USHIO Corp, Japan
  4. Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

向作者/读者索取更多资源

This review discusses the role of TGF-beta signaling in the proliferation, metastasis, and therapy response of prostate cancer cells. It also explores the regulation of TGF-beta signaling and its clinical application.
Transforming growth factor-beta (TGF-beta) is a member of a family of secreted cytokines with vital biological functions in cells. The abnormal expression of TGF-beta signaling is a common finding in pathological conditions, particularly cancer. Prostate cancer (PCa) is one of the leading causes of death among men. Several genetic and epigenetic alterations can result in PCa development, and govern its progression. The present review attempts to shed some light on the role of TGF-beta signaling in PCa. TGF-beta signaling can either stimulate or inhibit proliferation and viability of PCa cells, depending on the context. The metastasis of PCa cells is increased by TGF-beta signaling via induction of EMT and MMPs. Furthermore, TGF-beta signaling can induce drug resistance of PCa cells, and can lead to immune evasion via reducing the anti-tumor activity of cytotoxic T cells and stimulating regulatory T cells. Upstream mediators such as microRNAs and lncRNAs, can regulate TGF-beta signaling in PCa. Furthermore, some pharmacological compounds such as thymoquinone and valproic acid can suppress TGF-beta signaling for PCa therapy. TGF-beta over-expression is associated with poor prognosis in PCa patients. Furthermore, TGF-beta up regulation before prostatectomy is associated with recurrence of PCa. Overall, current review discusses role of TGF-beta signaling in proliferation, metastasis and therapy response of PCa cells and in order to improve knowledge towards its regulation, upstream mediators of TGF-beta such as non-coding RNAs are described. Finally, TGF-beta regulation and its clinical application are discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据